Is HeartSciences going out of business?

HeartSciences Inc. (HSCS) Fundamentals

A quick summary of the latest filed figures while the full analysis loads.

HeartSciences Inc. (HSCS) scores 11 out of 100 on fundamentals, Distressed / Caution, based on SEC filing data.

Leading signal: Shares dilution YoY: 174.40% (YoY) - Heavy dilution suggests continuous equity raises; survival depends on external capital.

Five questions, kept separate

Survival - Sector-specific review

Standard corporate cash-runway and leverage math is not meaningful for this non-bank financial company; a specialist solvency model is required.

Business quality - Evidence incomplete

Evidence incomplete financial Business Quality based on the bank evidence currently available.

Trajectory - Evidence incomplete

Comparable evidence covers 55% of this trajectory model. No comparable return on assets evidence.

Valuation - Extreme expectations

48.3x book value support an extreme expectations Valuation assessment for this financial company.

Event risk - Evidence unavailable

No active asserted adverse event was found in the available filing evidence. The filing evidence is stale or incomplete, so this is not proof of absence.

What the rules read

• Shares dilution YoY: 174.40% (YoY) - Heavy dilution suggests continuous equity raises; survival depends on external capital.
• ROE: -4044.00%
• Revenue CAGR (3Y): -5.70%
• Net income trend: 15.55%
• Debt Maturity Runway: 0% long-term (Near-term refinancing risk)
• Price / Earnings: Unprofitable (see Valuation)

Read from filings through 2026-07-23.

Price as of 2026-08-22.